Daiichi Sankyo files NDA for Prasugrel in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2013
Singapore: Japanese drug major Daiichi Sankyo submitted a New Drug Application to the Ministry of Health, Labor and Welf...Read more
Orient launches prostate cancer drug in SE Asia
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 May, 2014
Singapore: Orient EuroPharma, a specialty pharmaceutical company focused in marketing and commercialization has partnere...Read more
Innate Immunotherapeutics completes $9mn IPO
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 18 Dec, 2013
Singapore: Innate Immunotherapeutics has raised $8.9 million (AUD10 million) through its Initial Public Offer (IPO) that...Read more
Cadila Healthcare eyeing US, Europe markets
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 15 Sep, 2014
Singapore: With an eye on advanced markets like US and Europe, India's Cadila Healthcare has said that it would soon sta...Read more
Rock Creek granted Japanese, European, US Patent for lead compound
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 May, 2016
Rock Creek Pharmaceuticals Inc, a clinical-stage drug development company focused on the application of its lead compoun...Read more
Infect mosquitoes with Wolbachia, stop diseases
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Apr, 2013
Singapore: Scientists at Melbourne University and University of California have found that mosquito that are infected wi...Read more
LabCorp launches 4th gen HIV antigen assay
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Nov, 2013
Singapore: Laboratory Corporation of America has released 4th generation HIV antigen/antibody combination assay and a ne...Read more
FDA designates Chugai's bispecific antibody as breakthrough therapy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Sep, 2015
Japan's pharma giant, Chugai Pharmaceutical Co. has reported that the US Food and Drug Administration (FDA) has granted ...Read more
NZ gets drug that glows brain tumour
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Sep, 2015
Singapore: A novel drug, GLIOLAN (aminolevulinic acid HCl), that helps neurosurgeons to better visualise and remove mali...Read more
Singapore develops animal-free screening platform to predict nephrotoxicity
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Oct, 2015
Singapore: Researchers from Singapore's Institute of Bioengineering and Nanotechnology (IBN) have developed an animal-fr...Read more
Shionogi's constipation drug phase III study shows significant improvement
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 Feb, 2016
The US subsidiary of Osaka-based Shionogi has announced results of its pivotal phase III study (COMPOSE I). The study re...Read more
LBT Innovations inks partnership with French tech firm
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2015
Singapore: Australian medical technology company, LBT Innovations, has signed a license agreement with French in vitro d...Read more
CARsgen partners with Shanghai Cancer Institute to develop cancer immunotherapies
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Sep, 2015
Singapore: China based CARsgen Therapeutics, a private and venture backed company focused on the development of CAR-T-ba...Read more
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Jul, 2014
Singapore: Actavis has recieved US Federal Trade Commission (FTC) nod to acquire Forest Laboratories following a propose...Read more
Phylogica appoints CEO, CSO, CFO
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2013
Singapore: Leading Australian peptide drug discovery company Phylogica appointed Dr Richard Hopkins as the company's new...Read more
Kowa Pharma and Eli Lilly release PK study result
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2012
Singapore: Kowa Pharmaceuticals and Eli Lilly released results from a pharmacokinetic (PK) study exploring potential dru...Read more
TWi's diabetes drug recieves patent allowance from Europe, Russia
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 03 Aug, 2015
Singapore: Taiwan based TWi Biotechnology has received patent allowance for AC-201, its lead drug candidate, from the Eu...Read more
Japanese stem cell company ReproCELL acquires Biopta
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 26 Nov, 2015
Tokyo: Japanese regenerative medicine company ReproCELL Inc. has announced the acquisition of the Scottish life science...Read more